Laparoscopic Duodenal Closure (Perforated Duodenal Ulcer Repair): Procedure, Outcomes and Recovery — Overview, Diagnosis & Treatment Options | MyMedicPlus

Perforated duodenal ulcer is a life-threatening complication of peptic ulcer disease in which a chronic or acute ulcer erodes through the full thickness of the duodenal wall, allowing duodenal and gastric contents to spill into the peritoneal cavity, causing chemical peritonitis that progresses rapidly to bacterial peritonitis and septic shock. The duodenal bulb (first part) is the most common perforation site, typically on the anterior wall. Perforated peptic ulcer occurs in approximately 2–10 per 100,000 population per year, most commonly in males and older patients. Laparoscopic duodenal closure — minimally invasive closure of the perforation using a Graham omental patch (a pedicled tongue of omentum sutured over the perforation site) — has become the preferred approach at centers with laparoscopic expertise, demonstrating equivalent outcomes to open repair with reduced wound complications, shorter hospital stay, and faster recovery. Operative mortality ranges from 6–10% in low-risk patients to over 30% in elderly patients with delayed presentation, shock, or significant comorbidities.

The pathogenesis of duodenal ulcer is a relative imbalance between aggressive factors (acid, pepsin) and mucosal protective mechanisms. Helicobacter pylori infection is present in 80–90% of patients with duodenal ulcer and causes chronic active duodenitis that impairs mucosal defense. NSAIDs (ibuprofen, diclofenac, aspirin, naproxen, ketorolac) are the second most important cause — they inhibit COX-1-mediated prostaglandin synthesis, reducing mucosal protective bicarbonate and mucus secretion; risk is highest with higher doses, older age, concurrent corticosteroid use, and prior ulcer history. Smoking doubles the risk of duodenal ulcer perforation by impairing mucosal blood flow and bicarbonate secretion. Corticosteroids alone carry minimal ulcer risk but act synergistically with NSAIDs (concurrent use increases perforation risk 15-fold). Physiological stress (ICU patients, post-major surgery, severe burns — Curling's ulcer; head injury — Cushing's ulcer) causes stress ulcers. Zollinger-Ellison syndrome (gastrin-secreting tumor) causes severe acid hypersecretion and ulceration refractory to standard doses of PPIs.

Perforated duodenal ulcer classically presents with sudden-onset, severe epigastric pain — often described as 'like a knife' — that rapidly spreads to involve the entire abdomen within hours as peritonitis establishes. The pain is constant and severe, typically worsened by movement (peritoneal irritation). In the first hours (chemical peritonitis), the patient is distressed but hemodynamically stable; as bacterial peritonitis supervenes (12–24 hours), systemic sepsis develops with tachycardia, hypotension, fever, and oliguria. Physical examination demonstrates a rigid, board-like abdomen — the cardinal sign of peritonitis — with diffuse tenderness, rebound tenderness, and absent bowel sounds. Referred pain to the right shoulder (diaphragmatic irritation from subphrenic air or fluid) is reported in 50% of patients. Note: up to 10–20% of elderly patients may have an atypical presentation without severe pain due to blunted pain perception, leading to dangerous diagnostic delay.

Clinical diagnosis is supported by imaging. Erect chest X-ray or erect abdominal X-ray demonstrates free air under the diaphragm (pneumoperitoneum) in 70–80% of perforated peptic ulcers — the key radiological finding. CT abdomen with IV contrast is the investigation of choice when perforation is suspected but chest X-ray is negative or diagnosis is uncertain: it identifies free air, free fluid, site of perforation, and local complications with sensitivity exceeding 95%. Water-soluble contrast swallow (Gastrografin) is rarely needed for pre-operative localization. Blood tests reveal leukocytosis, elevated CRP, hyperamylasaemia (from peritoneal absorption of duodenal contents), and metabolic acidosis in advanced cases. Serum lactate and Boey score (serum creatinine >130 µmol/L, ASA class ≥3, and >24h symptom-to-presentation interval) predict mortality and guide operative risk assessment. H. pylori testing (urease breath test, stool antigen, or serology) is performed to guide post-operative eradication therapy.

Emergency resuscitation with IV fluids, nasogastric decompression, urinary catheter, IV broad-spectrum antibiotics (cefuroxime + metronidazole, or piperacillin-tazobactam in severe peritonitis), IV PPI infusion (omeprazole 80 mg bolus then 8 mg/h), and analgesia are initiated simultaneously with surgical preparation. Laparoscopic simple closure with Graham omental patch — the procedure of choice at experienced centers — involves placing 2–3 absorbable sutures across the perforation edge, and securing a well-vascularized pedicle of omentum over the repair; peritoneal lavage with 6–10 litres of warm saline is performed. Open Graham patch (laparotomy) is performed when laparoscopy is contraindicated, conversion is required, or laparoscopic expertise is unavailable. Definitive acid-reducing surgery (vagotomy + pyloroplasty or antrectomy) is rarely performed today as PPI therapy and H. pylori eradication eliminate the ulcer diathesis. Post-operatively: IV PPI for 72 hours, then oral PPI (omeprazole 20–40 mg) for 8 weeks; H. pylori eradication with triple or quadruple therapy after recovery; lifelong NSAID avoidance or GI-protective co-prescribing if NSAIDs cannot be stopped.

Prognosis after laparoscopic repair of perforated duodenal ulcer depends primarily on the patient's preoperative physiological status and timing of presentation. Boey score risk stratification predicts mortality: low-risk patients (Boey 0: no shock, no major comorbidity, symptoms <24 hours) have operative mortality below 2%; Boey 3 (all three risk factors present) carries mortality of 100% in some series, reflecting the impact of delayed presentation and physiological deterioration. Overall 30-day mortality ranges from 6–10% in younger, fit patients to 20–30% in elderly patients with delayed presentation or septic shock. Successful H. pylori eradication after repair reduces ulcer recurrence from 60–80% to under 5–10% at 1 year. After uncomplicated laparoscopic repair in fit patients, most are discharged within 3–7 days, return to normal activities within 4–6 weeks, and have no long-term dietary restrictions if H. pylori is eradicated and NSAIDs are avoided. Re-leak after repair occurs in 2–5% of cases and requires reoperation. Long-term, the perforation site heals completely; the risk of subsequent perforation without H. pylori eradication is substantial (15–20% within 2 years). Endoscopy at 6–8 weeks confirms ulcer healing and H. pylori eradication status. Patients who require emergency laparotomy and prolonged ICU care have higher complication rates (intra-abdominal abscess, anastomotic leak, respiratory failure), but most recover fully with appropriate multi-disciplinary care.

H. pylori eradication with first-line triple therapy (PPI + clarithromycin + amoxicillin for 14 days, or bismuth quadruple therapy in clarithromycin-resistant areas) achieves cure in 85–95% of cases and markedly reduces ulcer recurrence and re-perforation risk. All patients with a history of peptic ulcer or perforation should have H. pylori status confirmed and eradicated. High-risk NSAID users should receive co-prescribing with a full-dose PPI (omeprazole, esomeprazole) or use a COX-2 selective inhibitor (celecoxib) — which has a lower GI perforation risk than non-selective NSAIDs. Aspirin users at high GI risk (prior ulcer, age >65, concurrent NSAID or anticoagulant) should receive a PPI. Smoking cessation significantly reduces both peptic ulcer incidence and healing time. Patients with Zollinger-Ellison syndrome require high-dose PPI therapy or surgical treatment of the gastrinoma.

Perforated duodenal ulcer is a surgical emergency — delay in treatment beyond 12–24 hours doubles operative mortality. Any patient with sudden-onset severe abdominal pain, particularly with a prior history of ulcer disease or NSAID use, must call emergency services or attend the emergency department immediately — do not wait for the pain to resolve. A rigid, board-like abdomen on examination requires immediate surgical referral. Elderly patients, immunosuppressed individuals, and those on corticosteroids may have atypical presentations — a high index of suspicion must be maintained for any new-onset abdominal discomfort in these populations. After recovery from perforation, all patients must be reviewed by a gastroenterologist for H. pylori eradication confirmation, ulcer healing check by endoscopy at 6–8 weeks, and long-term PPI/NSAID counselling.